How Do I Know if I Might Have Ovarian Cancer?

Translate to Spanish or other 102 languages!

In 2020, the latest year for which incidence data are available, in the United States, 18,518 new cases of ovarian cancer were reported among women, and 13,438 women died of this cancer. Image for illustration purposs
In 2020, the latest year for which incidence data are available, in the United States, 18,518 new cases of ovarian cancer were reported among women, and 13,438 women died of this cancer. Image for illustration purposs

Mega Doctor News

- Advertisement -

In 2020, the latest year for which incidence data are available, in the United States, 18,518 new cases of ovarian cancer were reported among women, and 13,438 women died of this cancer. For every 100,000 women, 9 new Ovarian cancer cases were reported and 6 women died of this cancer.

Cancer is the second leading cause of death in the United States, exceeded only by heart disease. One of every five deaths in the United States is due to cancer.

In Texas in 2020, among all races and ethnicities, the age-adjusted rate of ovarian cancer was 9.2 per 100,000 women and 1,463 ovarian cancer cases were reported. 

Our cancer expert can speak to the different types of ovarian cancer. What are the symptoms and treatments, and why it is so important that women get screenings and treatment.

- Advertisement -

Types of ovarian cancer: the type of cell where the cancer begins determines the type of ovarian cancer you have and helps your doctor determine which treatments are best for you. Ovarian cancer types include:

  • Epithelial ovarian cancer. This type is the most common. It includes several subtypes, including serous carcinoma and mucinous carcinoma.
  • Stromal tumors. These rare tumors are usually diagnosed at an earlier stage than other ovarian cancers.
  • Germ cell tumors. These rare ovarian cancers tend to occur at a younger age.
  • In 2023, 19,710 U.S. women are expected to be diagnosed with ovarian cancer, and approximately 13,270 will die.
  • Ovarian cancer is the leading cause of gynecologic cancer deaths. A woman’s lifetime risk of developing ovarian cancer is 1 in 78.

Information Source: TTUHSC EL Paso

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Despite a Cure, Millions Remain Untreated for Hepatitis C

Mega Doctor News by University of Virginia Newswise — CHARLOTTESVILLE, Va. – Millions of Americans...

Updated Guidance Seeks to Reduce Risks From Pulmonary Embolism

Mega Doctor News American Heart Association Clark was 32 in the fall of...

FDA Clears Path for Expanded Testosterone Therapy Options for Men

The U.S. Food and Drug Administration is taking an initial step to advance treatment options for men’s health by encouraging sponsors of approved testosterone replacement therapy (TRT) products to contact FDA for information if they are interested in pursuing a potential new indication for low libido in men with idiopathic hypogonadism (without a known cause).

Study Finds Persistent Barriers to Hormone Therapy for Cervical Cancer Patients

Most oncologists say they would prescribe hormone therapy to cervical cancer patients who experience early menopause from radiation treatment, but barriers are keeping many from doing so in practice, according to a new University of Kentucky Markey Cancer Center study published in JAMA Network Open.
- Advertisement -